AMR SVG Icons location

News / American Regent

American Regent Introduces HydrALAZINE Hydrochloride Injection, USP; “AP” Rated and Therapeutically Equivalent to Apresoline® 1,2

1 Jul 2021

Melville, NY – July 1, 2020: – American Regent announces the introduction and availability of HydrALAZINE Hydrochloride Injection, USP—“AP” Rated and therapeutically equivalent to Apresoline® 1,2.

Read more

Injectafer® (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

6 May 2021

Basking Ridge, N.J. and Shirley, N.Y. (May 6, 2021): Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron, have had unsatisfactory response to oral iron, or have non-dialysis dependent chronic kidney disease (CKD).1

Read more

American Regent, Inc. Announces New CEO

1 Apr 2021

Shirley, NYApril 1, 2021: Paul Diolosa assumed the role of President and CEO of American Regent, Inc., a Daiichi Sankyo Group company, effective today.

Read more

American Regent, Inc. introduces Tralement® (trace elements injection 4*, USP)

18 May 2020

Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of Tralement® (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.

Read more

American Regent, Inc. introduces Tralement® (trace elements injection 4*, USP)

30 Sep 2020

Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of Tralement® (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.

Read more

American Regent Introduces niCARdipine Hydrochloride Injection, USP­; Therapeutically Equivalent to Cardene®

7 May 2020

Shirley, NY – May 7, 2020: American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection. 

Read more

American Regent Introduces Estradiol Valerate Injection, USP; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2

3 Jun 2020

Shirley, NY – American Regent announces the introduction and availability of Estradiol Valerate Injection, USP

Read more

American Regent Introduces FDA Approved Zinc Sulfate Injection, USP

6 Jan 2020

Shirley, NY – American Regent, Inc. announced the introduction of FDA approved Zinc Sulfate Injection, USP.

Read more

American Regent Introduces FDA Approved 10 mg/10 mL Zinc Sulfate Injection, USP

18 May 2020

Shirley, NY – American Regent, Inc. announced the introduction of FDA approved Zinc Sulfate Injection, USP.

Read more

American Regent Announces the Launch and Availability of Selenious Acid Injection, USP­

2 Oct 2020

Shirley, NY - American Regent today announced the introduction of Selenious Acid Injection, USP.

Read more

American Regent Re-Introduces Aminocaproic Acid Injection, USP; AP Rated and Therapeutically Equivalent to Amicar®

28 Feb 2019

Shirley, NY - American Regent today announced the re-introduction of Aminocaproic Acid Injection, USP.

Read more

American Regent Re-introduces Droperidol Injection, USP; AP Rated and Therapeutically Equivalent to Inapsine®

Shirley, NY - American Regent, Inc. today announced the re-introduction of Droperidol Injection, USP.

Read more

Luitpold Pharmaceuticals, Inc. Renamed American Regent, Inc.

Luitpold Pharmaceuticals, Inc., a manufacturer and distributor of pharmaceuticals that addresses diverse medical and veterinary needs, announced it changed its legal name to American Regent, Inc. effective January 2, 2019.

Read more

St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship

The program offers fellowships in both Medical Affairs & Pharmaceutical Marketing and in Clinical Research & Development.

Read more

American Regent Announces the Availability of Methocarbamol Injection, USP; AP Rated and Therapeutically Equivalent to Robaxin®

30 Jan 2018

Shirley, NY — American Regent today announced the launch of Methocarbamol Injection, USP. Methocarbamol Injection, USP is available for immediate shipment. Customers can order Methocarbamol Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of FDA Approved 10% Calcium Chloride Injection, USP

16 Feb 2018

Shirley, NY — American Regent today announced the launch of 10% Calcium Chloride Injection, USP. 10% Calcium Chloride Injection, USP is available for immediate shipment. Customers can order 10% Calcium Chloride Injection, USP through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the Availability of Neostigmine Methylsulfate Injection, USP; AP Rated and Therapeutically Equivalent to Bloxiverz®

Shirley, NY — American Regent today announced the introduction of Neostigmine Methylsulfate Injection, USP. Product is available for immediate shipment and customers can order through their wholesaler/distributor or by contacting our Customer Support Group at 1-800-645-1706.

Read more

American Regent Announces the FDA Approval of Hydroxyprogesterone Caproate Injection, USP; the First Preservative Free, AP Rated Generic to Makena®

25 Jun 2018

Shirley, NY — American Regent today announced the launch of Hydroxyprogesterone Caproate Injection, USP, the only preservative free generic alternative to Makena®.

Read more

American Regent Announces the Launch and Availability of Fomepizole Injection, AP Rated and Therapeutically Equivalent to Antizol®

28 Aug 2018

Shirley, NY — American Regent today announced the launch and availability of Fomepizole Injection, AP rated and therapeutically equivalent to Antizol®.

Read more